IDenta Corp. (IDTA) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

IDenta Corp. (IDTA) Healthcare & Pipeline Overview

IDenta Corp. is a leader in the development of innovative detection solutions for narcotics and explosives, serving law enforcement and military agencies globally, with a strong focus on enhancing security measures in both public and private sectors.

What Is the Investment Thesis for IDTA?

IDenta Corp. presents a compelling investment thesis driven by its unique position in the growing homeland security market, which is projected to expand significantly due to increasing global security concerns. With a P/E ratio of 3.39 and a profit margin of 11.3%, the company demonstrates strong financial health relative to its peers. The ongoing demand for effective narcotics and explosives detection solutions is expected to drive revenue growth, particularly as governments worldwide enhance their security measures. Additionally, IDenta's gross margin of 53.2% indicates a robust operational efficiency, providing a solid foundation for future profitability. However, investors should remain cognizant of the risks associated with being an OTC Other tier stock, which may include limited liquidity and regulatory scrutiny. Monitoring the company's ability to secure contracts and maintain funding will be essential for assessing its long-term viability.

Based on FMP financials and quantitative analysis

IDTA Key Highlights

Market Cap: $0.00B, indicating a small-cap status with potential for growth.

• P/E Ratio: 3.39, significantly lower than industry averages, suggesting undervaluation.
• Profit Margin: 11.3%, showcasing operational efficiency in a competitive market.
• Gross Margin: 53.2%, reflecting strong product pricing power and cost management.
• Beta: 0.67, indicating lower volatility compared to the broader market.

Who Are IDTA's Competitors?

IDTA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are IDTA's Key Strengths?

Innovative product line tailored for security applications.

• Strong profit margins indicating operational efficiency.
• Established presence in the homeland security market.
• Experienced leadership with a focus on growth.

What Are IDTA's Weaknesses?

Limited market capitalization may restrict growth potential.

• Dependence on government contracts for revenue.
• Small employee base may limit operational capabilities.
• OTC trading status may deter some institutional investors.

What Could Drive IDTA Stock Higher?

Potential expansion of product line with new detection technologies.

• Strategic partnerships with law enforcement agencies to secure long-term contracts.
• Increased government spending on homeland security measures.
• Investment in R&D to improve product accuracy and efficiency.
• Growing international market presence to capture new customers.

What Are the Key Risks for IDTA?

Financial-distress signal — its Altman Z-Score of 0.65 sits in the distress zone (elevated bankruptcy risk).

• Dependence on government contracts may lead to revenue volatility.
• Intense competition from larger companies could impact market share.
• Regulatory challenges associated with OTC trading may affect investor confidence.
• Economic downturns could reduce government spending on security solutions.

What Are the Growth Opportunities for IDTA?

• Expansion of Product Line: IDenta Corp. plans to enhance its product offerings by developing new detection technologies tailored to emerging threats. The global market for drug detection technology is expected to reach $5 billion by 2028, providing a significant opportunity for IDenta to innovate and capture additional market share.
• International Market Penetration: With a focus on expanding its presence in international markets, IDenta aims to leverage its existing product portfolio to meet the growing demand for security solutions outside of Israel. The global homeland security market is projected to grow at a CAGR of 5.5% over the next five years, presenting a lucrative opportunity for IDenta's expansion.
• Strategic Partnerships: IDenta is exploring partnerships with law enforcement and military agencies to secure long-term contracts for its detection kits. Collaborations can enhance the company's credibility and lead to increased sales, particularly as governments prioritize funding for security technologies.
• Technological Advancements: The company is investing in R&D to improve the accuracy and efficiency of its detection kits. As technology evolves, there is a growing demand for advanced detection solutions, and IDenta's commitment to innovation could position it as a leader in this space.
• Increased Government Spending: As global security concerns rise, governments are likely to increase spending on homeland security measures. IDenta Corp. stands to benefit from this trend, particularly in the procurement of its detection kits for law enforcement and military applications.

What Threats Does IDTA Face?

• Intense competition from larger, established companies.
• Regulatory challenges in the OTC market.
• Economic downturns affecting government spending.
• Rapid technological changes requiring continuous innovation.

What Are IDTA's Competitive Advantages?

• Strong brand reputation in the homeland security sector.
• Innovative product offerings that address specific market needs.
• Established relationships with key government and law enforcement agencies.
• Expertise in forensic technology that enhances product reliability.
• Niche market focus that reduces competition from larger players.

What Does IDTA Do?

IDenta Corp. was founded in 1997 and is headquartered in Jerusalem, Israel. The company specializes in the development, manufacturing, and supply of field detection and home diagnostics testing kits aimed at identifying narcotics and explosives. Its product portfolio includes drug testing kits, explosives detection kits, bullet-hole testing products, FerroPrint testing solutions, blood detection kits, precursors of drugs test kits, and portable sniffers. These products are designed for use by law enforcement, military, and government agencies, as well as other organizations focused on combating illicit drug use and addressing terrorist threats. Over the years, IDenta has positioned itself as a key player in the homeland security sector, leveraging its expertise in forensic technology to meet the growing demand for reliable and efficient detection solutions. The company’s commitment to innovation and quality has enabled it to establish a strong presence in both domestic and international markets, catering to a diverse clientele that includes various governmental and security organizations. IDenta Corp. continues to evolve, adapting its offerings to meet the changing needs of the security landscape, thereby solidifying its role as a trusted provider of critical detection tools.

What Products and Services Does IDTA Offer?

• Develops and manufactures detection kits for narcotics and explosives.
• Supplies forensic products for law enforcement and security agencies.
• Offers home diagnostics testing kits for consumer markets.
• Provides specialized testing solutions for military applications.
• Focuses on enhancing safety and security through innovative technology.
• Caters to a global market with a diverse range of clients.

How Does IDTA Make Money?

• Generates revenue through the sale of detection kits and forensic products.
• Targets law enforcement, military, and government agencies as primary customers.
• Utilizes a direct sales model complemented by strategic partnerships.
• Focuses on innovation to develop new products in response to market needs.
• Leverages its expertise in forensic technology to maintain a competitive edge.

What Industry Does IDTA Operate In?

The medical diagnostics and research industry is experiencing robust growth, driven by increasing global security threats and the rising need for effective detection solutions. The market for homeland security is projected to expand significantly, with a focus on innovative technologies that enhance safety and security measures. IDenta Corp. operates within this dynamic landscape, facing competition from established players while also capitalizing on niche opportunities in narcotics and explosives detection. As governments and organizations allocate more resources to combat illicit activities, IDenta's specialized offerings position it well to capture market share and drive future growth.

Who Are IDTA's Key Customers?

• Law enforcement agencies seeking effective detection solutions.
• Military organizations requiring reliable forensic products.
• Government agencies focused on combating illicit drug use and terrorism.
• Private security firms looking for advanced detection technologies.
• Consumers interested in home diagnostics testing kits.

Company Profile

IDenta Corp. operates in the Medical - Specialties industry within the Healthcare sector. It is headquartered in Jerusalem, IL. The company is led by CEO Amichai Glattstein. IDTA has traded publicly since 2017.

Return on equity for IDenta Corp. stands at 22.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 9.7%, showing how much profit it generates from its asset base. IDTA trades at a trailing price-to-earnings ratio of 4.66, below the Healthcare sector average of ~23x. Its free cash flow yield is 7.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.94 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 21.5%, the inverse of the P/E and a quick read on earnings relative to price.

IDTA Valuation & Market Position

With a $1.21M market cap, IDenta Corp. sits in the micro-cap segment of the market. Relative to its peer group, IDTA's quantitative score of 56/100 is roughly in line with the peer average of 61/100.

Quarterly Financial Performance: IDenta Corp.

Revenue for IDenta Corp. came in at $521K during Q1 2026, a 31.3% improvement versus the preceding quarter. The company recorded net income of $30K, with diluted EPS of $0.01. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, IDTA averaged $0.01 in diluted EPS.

IDenta Corp.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.65 places it in the distress zone, a signal of elevated financial risk.

IDTA Financials

IDTA Latest News

No recent news available for IDTA.

IDTA Analyst Consensus

IDTA MoonshotScore

IDTA Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources